There's a strong desire for more longevity, gut health and holistic sleep solutions, according to McKinsey's Future of Wellness survey.
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
A Ro advisor, Dr. Rachel speaks about the confluence of mental and physical health in weight loss and misconceptions around GLP-1s.
Restore's new weight-loss program includes GLP-1s after an InBody scan and metabolic health blood panel.
Xponential is eyeing cross-collaborations between its fitness brands and Lindora, a chain of health clinics offering GLP-1s and wellness treatments.
ATN analyzes storylines to watch in 2024, including connected fitness, the rise of strength training and the emergence of weight loss drugs.
These eight fitness and wellness deals, partnerships and funding rounds made headlines in 2023 and could impact the industry for years to come.
As consumers flock to GLP-1s, major fitness industry players like Life Time and Xponential are eager to get in on the weight-loss drug craze.
Metabolic health clinic Lindora becomes Xponential's 11th brand and solidifies the fitness franchisor's entry into the broader wellness space.
Life Time's Miora clinic has a team of doctors, physician assistants, nurses and personal trainers, and includes weight loss drugs.
Sign Up to Our Newsletter
